Medifast Reports Q3 Earnings with Non-GAAP EPS and Revenue Beats
Medifast (NYSE: MED) reported third-quarter financial results that exceeded analyst expectations for both earnings per share and revenue. The company posted a Non-GAAP EPS of -$0.19, which outperformed estimates by $0.16, and recorded revenue of $72.05 million, surpassing consensus by $0.75 million. Despite the beats, Medifast faced significant year-over-year headwinds, with revenue declining 19.4% compared to the $89.4 million reported in the same quarter last year. The company currently maintains a network of 10,200 independent active earning coaches.
Tickers: $MED
Topics: earnings beat non-GAAP EPS revenue decline
Read the full article at Seeking Alpha
Part of the story Travelzoo Reports Q3 2026 Revenue Growth Amid Strategic Shift to Membership Model (4 articles)